Trial intelligence / Profile preview

Rocuronium vs Suxamethonium for RSI in Elderly

NCT04868409Phase 4Completed

Start
Aug 2021
Primary completion
Mar 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of rocuronium (2 arms). Primary endpoint: Intubation conditions. Started Aug 2021; status: completed.

02

Drugs

rocuronium

Beyond the preview

Go deeper on NCT04868409.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04868409.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call